Can rodents experience placebo and nocebo effects like we do? And if they can, are the underlying brain mechanisms actually the same as in humans? More importantly, can studying animals truly tell us anything meaningful about how placebo and nocebo shape pain in patients? Placebo analgesia and nocebo hyperalgesia are powerful modulators of pain, yet their neurobiological basis remains difficult to study directly in humans. Animal models offer a unique opportunity to probe underlying mechanisms, but a critical question remains: how well do these models translate?
In this webinar, Dr Boorman will present a novel cross-species approach designed to directly compare brain activity between humans and rodents during placebo and nocebo responses. By combining whole-brain activity mapping in rodents with neuroimaging in humans, a framework was developed to examine whether these phenomena share common neural substrates across species. This work aims to bridge a longstanding gap between preclinical and human research, providing new insight into whether animal models can reliably inform our understanding of pain modulation, and ultimately, whether they can help guide future clinical interventions.